Article
<i>TET2</i> lesions enhance the aggressiveness of <i>CEBPA-</i> mutant AML by rebalancing <i>GATA2</i> expression
2023-03-29
Abstract excerpt
<h4>ABSTRACT</h4> The myeloid transcription factor CEBPA is recurrently biallelically mutated (i.e., double mutated; CEBPA DM ) in acute myeloid leukemia (AML) with a combination of hypermorphic N-terminal mutations ( CEBPA NT ), promoting expression of the leukemia-associated p30 isoform, and amorphic C-terminal mutations. The most frequently co-mutated genes in CEBPA DM AML are GATA2 and TET2 , however the...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a2c04c15-d486-512f-a396-95013ceff88b
- DOI
- 10.1101/2023.03.28.534511
